vimarsana.com
Home
Live Updates
The combination of ISA101b and Libtayo® shows promising results in patients whose head and neck cancer progressed on anti-PD1 therapy : vimarsana.com
The combination of ISA101b and Libtayo® shows promising results in patients whose head and neck cancer progressed on anti-PD1 therapy
/PRNewswire/ -- ISA Pharmaceuticals B.V., a clinical-stage biotechnology company developing immunotherapies to treat cancers and serious infectious diseases,...
Related Keywords
Chicago ,
Illinois ,
United States ,
Netherlands ,
London ,
City Of ,
United Kingdom ,
Oegstgeest ,
Zuid Holland ,
Anthony Kong ,
Drug Administration ,
King College ,
Principal Investigator ,
Human Papilloma Virus ,
Medical Oncologist ,
Chief Medical Officer ,
Disease Control Rate ,
Fast Track ,
Isa Pharmaceuticalsbv ,
vimarsana.com © 2020. All Rights Reserved.